News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

Molecure has submitted a new application for approval to conduct a Phase II clinical trial for clinical candidate OATD-01 in the countries of the European Union and Norway

9 February 2024

Molecure invites to the R&D Day – an online scientific and educational meeting on February 6, 2024

29 January 2024

Molecure’s success in development of the mRNA discovery platform

12 December 2023

Molecure Announces Third Quarter 2023 Financial Results and Pipeline Highlights

31 October 2023

Molecure Announces First Half 2023 Results – Significant Financial and Operating Momentum

29 September 2023

Invitation to investor meeting 3rd October 2023, 2:00 pm (CET)

20 September 2023

Events & Presentations

ESMO – 8-12 September 2017 Madrid

1 September 2017

ERS – 9-13 September 2017 Milan

1 September 2017

BIO USA – San Diego 19-22 June 2017

1 June 2017

ATS – Washington 19-24 May 2017

1 May 2017
This site is registered on wpml.org as a development site.